These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27929198)

  • 21. Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.
    Tehrani S; Jörneskog G; Ågren A; Lins PE; Wallén H; Antovic A
    Thromb Haemost; 2015 Feb; 113(2):312-8. PubMed ID: 25318636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis.
    Sobczak AIS; Phoenix FA; Pitt SJ; Ajjan RA; Stewart AJ
    Thromb Haemost; 2020 Feb; 120(2):243-252. PubMed ID: 31942750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin therapy is associated with less compact fibrin networks and enhanced fibrinolysis in patients with abdominal aortic aneurysm.
    Bailey MA; Aggarwal R; Bridge KI; Griffin KJ; Iqbal F; Phoenix F; Purdell-Lewis J; Thomas T; Johnson AB; Ariëns RA; Scott DJ; Ajjan RA
    J Thromb Haemost; 2015 May; 13(5):795-801. PubMed ID: 25660763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.
    Collet JP; Moen JL; Veklich YI; Gorkun OV; Lord ST; Montalescot G; Weisel JW
    Blood; 2005 Dec; 106(12):3824-30. PubMed ID: 16091450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of gammaA/gamma' fibrin clots to fibrinolysis.
    Falls LA; Farrell DH
    J Biol Chem; 1997 May; 272(22):14251-6. PubMed ID: 9162058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function.
    Riedelová-Reicheltová Z; Kotlín R; Suttnar J; Geierová V; Riedel T; Májek P; Dyr JE
    Thromb Haemost; 2014 Jan; 111(1):79-87. PubMed ID: 24108601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Variants in the
    Simurda T; Brunclikova M; Asselta R; Caccia S; Zolkova J; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensing adhesion forces between erythrocytes and γ' fibrinogen, modulating fibrin clot architecture and function.
    Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Santos NC; Ariёns RAS
    Nanomedicine; 2018 Apr; 14(3):909-918. PubMed ID: 29410160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
    Piechocka IK; Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
    J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
    Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate.
    Collet JP; Nagaswami C; Farrell DH; Montalescot G; Weisel JW
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):382-6. PubMed ID: 14656741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
    Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
    Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism.
    Martinez MR; Cuker A; Mills AM; Crichlow A; Lightfoot RT; Chernysh IN; Nagaswami C; Weisel JW; Ischiropoulos H
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L397-404. PubMed ID: 24414255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia.
    Sauls DL; Wolberg AS; Hoffman M
    J Thromb Haemost; 2003 Feb; 1(2):300-6. PubMed ID: 12871504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heritability of clot formation, morphology, and lysis: the EuroCLOT study.
    Carter AM; Cymbalista CM; Spector TD; Grant PJ;
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2783-9. PubMed ID: 17932316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice.
    Ząbczyk M; Ariëns RAS; Undas A
    Cardiovasc Res; 2023 Mar; 119(1):94-111. PubMed ID: 36662542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced plasma fibrin clot permeability and susceptibility to lysis in patients with inflammatory bowel disease: a novel prothrombotic mechanism.
    Owczarek D; Cibor D; Sałapa K; Głowacki MK; Mach T; Undas A
    Inflamm Bowel Dis; 2013 Nov; 19(12):2616-24. PubMed ID: 24108112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications.
    Kearney KJ; Pechlivani N; King R; Tiede C; Phoenix F; Cheah R; Macrae FL; Simmons KJ; Manfield IW; Smith KA; Spurgeon BEJ; Naseem KM; Ariens RAS; McPherson MJ; Tomlinson DC; Ajjan RA
    Blood; 2019 Mar; 133(11):1233-1244. PubMed ID: 30545831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.
    Undas A; Kaczmarek P; Sladek K; Stepien E; Skucha W; Rzeszutko M; Gorkiewicz-Kot I; Tracz W
    Thromb Haemost; 2009 Dec; 102(6):1176-82. PubMed ID: 19967149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.